Default image

Approximating Isotope Distributions of Biomolecule Fragments

ACS Omega
September 2018

Dennis Goldfarb, Michael J. Lafferty, Laura E. Herring, Wei Wang, and Michael B. Major

Default image

Computer-Aided Design and Synthesis of 1-{4[(3,4-Dihydroxybenzylidene)amino]phenyl}-5-oxopyrrolidine-3-carboxylic Acid as an Nrf2 Enhancer

ChemPlusChem
February 2018

Shirin Kahremany, Ilana Babaev, Pinhas Hasin, Tigist Y. Tamir, Tali Ben-Zur, Guy Cohen, Zhengyu Jiang, Sagiv Weintraub, Daniel Offen, Shai Rahimipour, Michael B. Major, Hanoch Senderowitz, and Arie Gruzman

Default image

Hyperactivity of the transcription factor Nrf2 causes metabolic reprogramming in mouse esophagus

Journal of Biological Chemistry
November 2018

Junsheng Fu, Zhaohui Xiong, Caizhi Huang, Jing Li, Wenjun Yang, Yuning Han, Chorlada Paiboonrungruan, Michael B Major, Keneng Chen, Xiaozheng Kang, and Xiaoxin Luke Chen

Default image

P62-dependent phase separation of patient-derived KEAP1 mutations and NRF2

Molecular and Cellular Biology
August 2018

E.W. Cloer, P.F. Siesser, E.M. Cousins, D. Goldfarb, D.D. Mowrey, J.S. Harrison, S.J. Weir, N.V. Dokholyan, M.B. Major

Default image

Ponatinib shows potent antitumor activity in small cell carcinoma of the ovary hypercalcemic type (SCCOHT) through multi-kinase inhibition

Clinical Cancer Research
February 2018

Jessica D. Lang, William P.D. Hendricks, Krystal A. Orlando, Hongwei Yin, Jeffrey Kiefer, Pilar Ramos, Ritin Sharma, Patrick Pirrotte, Elizabeth A. Raupach, Chris Sereduk, Nanyun Tang, Winnie S. Liang, Megan Washington, Salvatore J. Facista, Victoria L. Zismann, Emily M. Cousins, Michael B. Major, Yemin Wang, Anthony N. Karnezis, Aleksandar Sekulic, Ralf Hass, Barbara C. Vanderhyden, Praveen Nair, Bernard E. Weissman, David G. Huntsman, and Jeffrey M. Trent

Default image

Targeted therapy of esophageal squamous cell carcinoma: the NRF2 signaling pathway as target

Annals of the NYAS
May 2018

Shaohua Ma, Chorlada Paiboonrungruan, Tiansheng Yan, Kevin P. Williams, Michael B. Major, and Xiaoxin Luke Chen

Default image

The Cancer/Testes (CT) Antigen HORMAD1 promotes Homologous Recombinational DNA Repair and Radioresistance in Lung adenocarcinoma cells

Scientific Reports
October 2018

Yanzhe Gao, Jordan Kardos, Yang Yang, Tigist Y. Tamir, Elizabeth Mutter-Rottmayer, Bernard Weissman, Michael B. Major, William Y. Kim, and Cyrus Vaziri